We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.16B
AUM Growth
-$38.5M
Cap. Flow
-$16.1M
Cap. Flow %
-1.39%
Top 10 Hldgs %
4.12%
Holding
2,179
New
583
Increased
522
Reduced
502
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 16.3%
2 Technology 15.76%
3 Financials 13.46%
4 Industrials 12.71%
5 Consumer Discretionary 10.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNLC icon
976
First Bancorp
FNLC
$399M
$393K 0.03%
14,873
+1,247
+9% +$32.2K
CHGG icon
977
Chegg
CHGG
$102M
$392K 0.03%
+421,155
New +$459K
ROIV icon
978
Roivant Sciences
ROIV
$26.2B
$392K 0.03%
+18,068
New +$356K
AGX icon
979
Argan
AGX
$8.37B
$391K 0.03%
1,247
-1,244
-50% -$395K
FAF icon
980
First American
FAF
$7.58B
$391K 0.03%
+6,368
New +$399K
OGN icon
981
Organon & Co
OGN
$3.57B
$391K 0.03%
54,545
-41,267
-43% -$326K
SM icon
982
SM Energy
SM
$6.87B
$391K 0.03%
20,894
-7,710
-27% -$156K
M icon
983
Macy's
M
$6.68B
$390K 0.03%
17,670
-36,637
-67% -$750K
APO icon
984
Apollo Global Management
APO
$73.4B
$389K 0.03%
+2,686
New +$357K
DLO icon
985
dLocal
DLO
$4.24B
$389K 0.03%
+27,487
New +$388K
LRMR icon
986
Larimar Therapeutics
LRMR
$432M
$389K 0.03%
102,039
+20,633
+25% +$80.2K
RVLV icon
987
Revolve Group
RVLV
$1.73B
$389K 0.03%
12,898
-42,710
-77% -$1.03M
Q
988
Qnity Electronics Inc
Q
$28.9B
$388K 0.03%
+4,756
New +$404K
NVR icon
989
NVR
NVR
$17B
$387K 0.03%
+53
New +$396K
ASYS icon
990
Amtech Systems
ASYS
$272M
$386K 0.03%
30,748
-3,069
-9% -$27.6K
CGNX icon
991
Cognex
CGNX
$11.3B
$386K 0.03%
10,720
+3,677
+52% +$149K
CME icon
992
CME Group
CME
$94.8B
$386K 0.03%
1,413
-3,363
-70% -$914K
GMED icon
993
Globus Medical
GMED
$11.2B
$386K 0.03%
+4,421
New +$336K
ICHR icon
994
Ichor Holdings
ICHR
$2.56B
$386K 0.03%
20,940
+114
+0.5% +$2.11K
NMRK icon
995
Newmark Group
NMRK
$2.63B
$386K 0.03%
+22,257
New +$390K
SGC icon
996
Superior Group of Companies
SGC
$225M
$386K 0.03%
39,845
+23,398
+142% +$229K
RAPP
997
Rapport Therapeutics
RAPP
$2.18B
$386K 0.03%
+12,733
New +$352K
MLI icon
998
Mueller Industries
MLI
$15.2B
$385K 0.03%
6,708
-8,926
-57% -$480K
RNR icon
999
RenaissanceRe
RNR
$13.4B
$385K 0.03%
1,370
-563
-29% -$148K
RUN icon
1000
Sunrun
RUN
$2.46B
$385K 0.03%
20,936
-59,647
-74% -$1.14M

Similar funds

GSA Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, GSA Capital Partners held 2,179 positions worth $1.16B, down 3.2% from $1.2B the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

GSA Capital Partners's Q4 2025 filing shows 583 new, 522 increased, 502 reduced and 562 closed positions. Its largest new stake was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M. The largest sale was Nuvation Bio, an estimated $6.32M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GSA Capital Partners's largest Q4 2025 buy was iShares Floating Rate Bond ETF: 137,329 shares worth $6.99M.
  • GSA Capital Partners added most to Remitly in Q4 2025, an estimated $4.91M increase.
  • GSA Capital Partners's biggest Q4 2025 reduction was Nuvation Bio, cutting an estimated $6.32M.
  • GSA Capital Partners fully exited Jefferies Financial Group in Q4 2025, selling an estimated $3.77M.
  • GSA Capital Partners's ten largest holdings make up 4.1% of its $1.16B portfolio in Q4 2025.
  • GSA Capital Partners opened 583 new positions and closed 562 in Q4 2025.
  • GSA Capital Partners's portfolio value fell 3.2% quarter-over-quarter to $1.16B.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.